Newsroom Archives
View Latest Press Releases >>
2017
- HeartFlow Announces Decision by Centers for Medicare & Medicaid Services to Assign a New Technology Payment Classification to HeartFlow® FFRCT Analysis
- Philips and HeartFlow Announce Global Collaboration Agreement
- GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
- HeartFlow Names Former J&J Chairman and CEO William C. Weldon Chairman of the Board
- HeartFlow Names Healthcare Industry Veteran Michael Buck as Executive Vice President and Chief Commercial Officer
- Siemens Healthineers and HeartFlow® Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs
- NICE Guidance Recommends HeartFlow FFRCT Analysis to Help Determine Cause of Stable Chest Pain in Patients
2016
- HeartFlow FFRCT Analysis Receives Regulatory Approval in Japan
- Providence Health Care Becomes First Canadian Center to Adopt Revolutionary HeartFlow FFRCT Analysis to Assess Coronary Artery Disease
- HeartFlow Introduces Next Generation Platform
- Technology from HeartFlow Provides Insights to Help Identify Coronary Plaques at Risk of Rupturing
- Highmark Health’s VITAL program partners with Allegheny Health Network and HeartFlow to evaluate a novel 3D technology
- One-Year PLATFORM Trial Results Reinforce Benefits of the HeartFlow FFRCT Analysis for Assessing Coronary Artery Disease
2015
- Trial Demonstrates HeartFlow FFRCT Analysis Significantly Lowers Cost of Care, Improves Quality of Life for Coronary Artery Disease
- HeartFlow Secures 50th U.S. Patent
- PLATFORM Trial Shows HeartFlow FFRCT Analysis Significantly Decreases Unnecessary Invasive Diagnostic Testing for Coronary Artery Disease
- Technology Industry Veteran Phil Mui Joins HeartFlow Product & Engineering Team
- FFRCT RIPCORD Study: Availability of HeartFlow FFRCT Analysis Changes the Management of Patients with Coronary Artery Disease
- Kent Walker Joins HeartFlow Board of Directors
2014
- HeartFlow Names New General Counsel to Executive Team
- HeartFlow Appoints Former Johnson & Johnson Chairman and CEO William C. Weldon to Board of Directors
- HeartFlow Secures De Novo Clearance from the U.S. Food and Drug Administration for Breakthrough FFRCT Technology
- HeartFlow Announces Appointment of Several Key Executive Hires